Table 1 Clinicopathological characteristics of UCEC patients used in this study
From: A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma
Variables |  | TCGA cohort (n = 301) | Discovery cohort (n = 150) | Validation cohort (n = 151) | P-value |
|---|---|---|---|---|---|
Stage, no(%) | I | 207 (68.8) | 106 (70.7) | 101 (66.9) | 0.726a |
| Â | II | 16 (5.3) | 9 (6) | 7 (4.6) | Â |
| Â | III | 64 (21.3) | 30 (20) | 34 (22.5) | Â |
| Â | IV | 13 (4.3) | 5 (3.3) | 8 (5.3) | Â |
Grade, no(%) | 1 | 70 (23.3) | 33 (22) | 37 (24.5) | 0.619a |
| Â | 2 | 81 (26.9) | 38 (25.3) | 43 (28.5) | Â |
| Â | 3 | 150 (49.8) | 79 (52.7) | 71 (47) | Â |
histology, no(%) | Endometrioid | 243 (80.7) | 124 (82.7) | 119 (78.8) | 0.664a |
| Â | Serous | 50 (16.6) | 22 (14.7) | 28 (18.5) | Â |
| Â | Mixed | 8 (2.7) | 4 (2.7) | 4 (2.6) | Â |
Vital status, no(%) | Alive | 270 (89.7) | 133 (88.7) | 137 (90.7) | 0.69a |
| Â | Dead | 31 (10.3) | 17 (11.3) | 14 (9.3) | Â |
Age, years (mean ± SD) |  | 63.4 ± 10.7 | 63.7 ± 11.1 | 63.0 ± 10.4 | 0.537b |